US 11975062
Zika vaccines and immunogenic compositions, and methods of using the same
granted A61KA61K2039/5252A61K2039/545
Quick answer
US patent 11975062 (Zika vaccines and immunogenic compositions, and methods of using the same) held by Takeda Vaccines, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K2039/5252, A61K2039/545, A61K39/12, A61P